We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGRY icon
251
Surgery Partners
SGRY
$1.97B
$221K 0.07%
10,229
+5,036
+97% +$112K
TDW icon
252
Tidewater
TDW
$4.53B
$217K 0.07%
4,080
+3,123
+326% +$171K
VIG icon
253
Vanguard Dividend Appreciation ETF
VIG
$115B
$215K 0.07%
+1,000
New +$210K
BSX icon
254
Boston Scientific
BSX
$75.1B
$214K 0.07%
+2,200
New +$228K
SOPH icon
255
SOPHiA GENETICS
SOPH
$644M
$212K 0.07%
+44,705
New +$154K
CVS icon
256
CVS Health
CVS
$121B
$211K 0.07%
2,807
+2,138
+320% +$147K
HOUS
257
DELISTED
Anywhere Real Estate
HOUS
$211K 0.07%
+20,000
New +$118K
INSP icon
258
Inspire Medical Systems
INSP
$1.68B
$211K 0.07%
+2,848
New +$288K
CENX icon
259
Century Aluminum
CENX
$4.66B
$209K 0.07%
+7,140
New +$162K
IMXI icon
260
International Money Express
IMXI
$354M
$209K 0.07%
+15,000
New +$186K
MSOX icon
261
AdvisorShares MSOS 2X Daily ETF
MSOX
$59.5M
$205K 0.07%
+26,452
New +$168K
VOT icon
262
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
$205K 0.07%
+700
New +$202K
WENN
263
Wen Acquisition Corp
WENN
$202K 0.06%
+20,000
New +$204K
BRK.B icon
264
Berkshire Hathaway Class B
BRK.B
$1.09T
$201K 0.06%
401
+267
+199% +$129K
GTLS
265
DELISTED
Chart Industries
GTLS
$200K 0.06%
+1,000
New +$190K
DNA icon
266
Ginkgo Bioworks
DNA
$491M
$197K 0.06%
13,565
-136,406
-91% -$1.63M
ADMA icon
267
ADMA Biologics
ADMA
$2.1B
$196K 0.06%
+13,400
New +$230K
MOB
268
Mobilicom Ltd
MOB
$72.5M
$196K 0.06%
+21,100
New +$106K
EVH icon
269
Evolent Health
EVH
$517M
$191K 0.06%
+22,632
New +$220K
BELFA icon
270
Bel Fuse Inc Class A
BELFA
$3.43B
$190K 0.06%
1,637
+1,066
+187% +$117K
SIMO icon
271
Silicon Motion
SIMO
$8.48B
$190K 0.06%
2,014
-2,457
-55% -$195K
GAP
272
The Gap Inc
GAP
$7.31B
$186K 0.06%
8,736
-28,305
-76% -$612K
ONTO icon
273
Onto Innovation
ONTO
$20.7B
$185K 0.06%
+1,433
New +$153K
T icon
274
AT&T
T
$169B
$185K 0.06%
6,580
-2,880
-30% -$81.8K
CEPF
275
Cantor Equity Partners IV
CEPF
$596M
$185K 0.06%
+18,199
New +$185K
9 10
11
12 13

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.